Linperlisib Recruiting Phase 2 Trials for Peripheral T/NK Cell Lymphoma (R/R PTCL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05274997A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma